Example sentences of "[art] legend [prep] [noun sg] [adj] " in BNC.
Next page| No | Sentence |
|---|---|
| 1 | To date , five species are known which contain a group I intron at an identical position of the mtLSUrRNA ( Fig. 3 ) : the four ascomycetes P.anserina ( intron ri2 ) , N.crassa ( intron ri1 ) , A.nidulans ( intron ri1 ) , S.cerevisiae ( intron ri1 ) and P.wickerhamii ( intron ri1 ) ( references are given in the legend of Fig. 3 ) . |
| 2 | Experimental conditions were as described in the legend to Figure 5 . |
| 3 | Details of wounding are given in the legend to Table 1 . |
| 4 | Sugar conformations and glycosidic rotation angles have been estimated as described in the legend to Table 1 . |
| 5 | 32 P-labelled fragments ( final concentration 1 nM ) , proteins at the concentrations stated in the legend to Fig. 4 and competitor DNA were incubated as in the gel retardation experiments . |
| 6 | Details of crystallization , data collection , MIR phase determination , structure refinement and overall structure description are given in Table 1 and the legend to Fig. 1 . |
| 7 | Trunk fragments with attached limbs ( +AER and -AER ) were cultured as described in the legend to Fig. 1 for 48h in serum-free medium supplemented as stated ( resupplemented after 24h ) . |
| 8 | Peptide stimulations and CTL assays were done essentially as described in the legend to Fig. 2 . |
| 9 | Introduction of plasmid DNA into the mouse airways was as described in the legend to Fig. 2 . |
| 10 | The observed increase in -AER limb length results from increased cell division in distal limb mesenchyme , as demonstrated by the finding that the frequency of bromodeoxyuridine(BrdU)-labelled mesenchyme cells is 33% ( 4.5% ) in FGF-4 stimulated -AER limbs , but only 4% ( 0.7% ) in contralateral +AER limbs ( method described in the legend to Fig. 3 ) . |
| 11 | The Mam I- Sfa NI , Mam I- Sau 3A and Xba I- Pvu II deoP2 fragments were purified by electrophoresis on polyacrylamide gels after labelling of the 5'-end of the Mam I site with polynucleotide kinase in the presence of γ- 32 P-ATP and the 3'-end of the Xba I site with Klenow fragment in the presence of α- 32 P-dCTP. 0.8 nM of the labelled fragments and various concentrations ( indicated in the Legend in Fig. 3 ) of CytR or CRP were incubated in binding buffer ( 10 mM Tris HCl ( pH 7.8 ) , 50 mM KCl , 1 mM EDTA , 50 µg/ml acetylated bovine serum albumine , 1 mM dithiothreitol , 0.05 % Nonidet-P40 ) containing 20 µg/ml competitor DNA ( pGEM4 obtained from Promega ) for 30 min. at 37°C in a total volume of 10 µl ( 6 ) . |